Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents
Am J Cardiovasc Drugs. 2025 Aug 28. doi: 10.1007/s40256-025-00757-6. Online ahead of print. ABSTRACT Bruton tyrosine kinase… Read More